Financhill
Back

Recruit Holdings Co., Ltd. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Buy
58

RCRUY
Recruit Holdings Co., Ltd.

Last Price:
$11.35
Seasonality Move:
-4.29%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.82
Seasonality Move:
11.35%
Buy
58
Recruit Holdings Co., Ltd. (RCRUY) is a Buy

Is Recruit Holdings Co., Ltd. a Buy, Sell or Hold?

  • The current Recruit Holdings Co., Ltd. [RCRUY] share price is $11.35. The Score for RCRUY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • RCRUY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.85. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RCRUY Stock Price Chart

What is Recruit Holdings Co., Ltd.'s stock price today?

  • The Recruit Holdings Co., Ltd. share price today is $11.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCRUY is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.

RCRUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.51 Buy
Relative Strength Index (14 RSI): 64.15 Buy
Chaikin Money Flow: 55347 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.92 - 10.94) Buy
Bollinger Bands (100): (10.09 - 11.61) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.79 Buy
Relative Strength Index (14 RSI): 85.13 Buy
Chaikin Money Flow: -64999 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.24 - 220.64) Buy
Bollinger Bands (100): (56.58 - 180.88) Buy

RCRUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.01 Buy
20-day SMA: 10.59 Buy
50-day SMA: 10.33 Buy
200-day SMA: 11.01 Buy
8-day EMA: 7.16 Buy
20-day EMA: 3.72 Buy
50-day EMA: 1.66 Buy
200-day EMA: 0.44 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.41 Buy
20-day SMA: 220.21 Buy
50-day SMA: 164.03 Buy
200-day SMA: 74.75 Buy
8-day EMA: 220.29 Buy
20-day EMA: 211.51 Buy
50-day EMA: 175.19 Buy
200-day EMA: 95.79 Buy

Recruit Holdings Co., Ltd. Earnings Growth & RCRUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Recruit Holdings Co., Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):